---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-24-000467"
form_type: "8-K"
ticker: "VTAK"
cik: "0001716621"
company_name: "Catheter Precision, Inc."
filed_at: "2024-01-11T23:59:59+00:00"
generated_at: "2026-06-07T00:35:52.038019+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Catheter Precision reports preliminary 2023 revenue $442K, net loss $72.4M including $61M goodwill impairment

## Summary
- Q4 2023 revenue ~$129K; full-year revenue ~$442K.
- Preliminary net loss: Q4 ~($2.5M), FY ~($72.4M) includes $61M one-time goodwill impairment.
- Cash on hand $3.6M; shareholders equity $19.4M as of Dec 31, 2023.
- Launched LockeT closure product; enrolled 100+ patients in Phase I study; IRB approved Phase II.
- VIVO active in six European countries; IP portfolio expanded to 50 patents worldwide.

## SEC filing metadata
- accession: 0001654954-24-000467
- form_type: 8-K
- ticker: VTAK
- cik: 0001716621
- company_name: Catheter Precision, Inc.
- filed_at: 2024-01-11T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1716621/000165495424000467/0001654954-24-000467-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1716621/000165495424000467/rmed_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-24-000467
- JSON: https://secwatch.observer/filing/0001654954-24-000467.json
- Plain text: https://secwatch.observer/filing/0001654954-24-000467.txt

## Key facts
- Earnings Releases
  Catheter Precision, Inc. reported fourth quarter and full year ended December 31, 2023 results: revenue $129,000 for the quarter and $442,000 for the year, net income net loss was approximately ($2.5) million for the quarter and ($72.4) million for the year.
  - Period: fourth quarter and full year ended December 31, 2023
  - Revenue: $129,000 for the quarter and $442,000 for the year
  - Net income: net loss was approximately ($2.5) million for the quarter and ($72.4) million for the year
  - Result: preliminary results
  source text: results of the fourth quarter and year ended December 31, 2023, include the following: · Total revenues for the quarter and year ended December 31, 2023, were approximately $129,000 and $442,000, respectively. · Total cash on hand as of December 31, 2023, was approximately $3.6 million. · Total assets as of December 31, 2023, subject to adjustment, was $30.7
  evidence_url: https://www.sec.gov/Archives/edgar/data/1716621/000165495424000467/0001654954-24-000467-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.